BlackRock Institutional Trust’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlackRock Institutional Trust’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.63M	Buy	923,722 +27,201	+3%	+$220K	﹤0.01%	2619
2016 Q3	$8.39M	Buy	896,521 +27,005	+3%	+$224K	﹤0.01%	2439
2016 Q2	$5.5M	Buy	869,516 +109,243	+14%	+$703K	﹤0.01%	2631
2016 Q1	$4.2M	Buy	760,273 +15,287	+2%	+$57.5K	﹤0.01%	2755
2015 Q4	$4.16M	Sell	744,986 -13,017	-2%	-$86K	﹤0.01%	2809
2015 Q3	$6.41M	Buy	758,003 +239,179	+46%	+$4.05M	﹤0.01%	2572
2015 Q2	$7.84M	Buy	518,824 +16,818	+3%	+$243K	﹤0.01%	2545
2015 Q1	$8.04M	Buy	502,006 +140,676	+39%	+$2.5M	﹤0.01%	2529
2014 Q4	$6.44M	Buy	361,330 +76,234	+27%	+$950K	﹤0.01%	2614
2014 Q3	$2.86M	Buy	285,096 +12,831	+5%	+$156K	﹤0.01%	2914
2014 Q2	$4.25M	Sell	272,265 -42,985	-14%	-$609K	﹤0.01%	2856
2014 Q1	$5.85M	Buy	315,250 +214,672	+213%	+$4.3M	﹤0.01%	2724
2013 Q4	$1.92M	Buy	100,578 +25,689	+34%	+$522K	﹤0.01%	3184
2013 Q3	$1.22M	Buy	+74,889	New	+$787K	﹤0.01%	3305

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's PETX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Aratana Therapeutics, Inc. (PETX) stake by 3% in Q4 2016, buying an estimated $220K and bringing the position to 923,722 shares worth $6.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

BlackRock Institutional Trust first reported a position in PETX in Q3 2013 and has held it in 14 quarters since. The position peaked at $8.39M in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

BlackRock Institutional Trust held 923,722 shares of Aratana Therapeutics, Inc. worth $6.63M as of Q4 2016.
BlackRock Institutional Trust bought 27,201 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $220K.
Aratana Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2619 holding.
BlackRock Institutional Trust first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and has held it in 14 quarters since.
BlackRock Institutional Trust's Aratana Therapeutics, Inc. position peaked at $8.39M in Q3 2016.
107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.